NICHD News

​​​NICHD issues News Releases and
Media Advisories to the news media. Spotlight and
Research Feature articles explain NICHD research findings and public health issues to the general public. An
Item of Interest is a short announcement of relevant information, such as a notable staff change.​

An experimental drug appears to slow the progression of Niemann-Pick disease type C1 (NPC1), a fatal neurological disease, according to results of a
clinical study led by researchers at the National Institutes of Health (NIH). The study appears in
The Lancet.